United States News Todas as matérias

OpenWorld (NASDAQ:OPNW) signed a definitive agreement to acquire Blocksight, supporting two proposed tokenized financing programs worth up to US$1.13 billion combined.

Red Cat Holdings (NASDAQ:RCAT) proposed acquiring Steyr Motors for €39 per share in cash, representing a 28.9% premium to the Austrian manufacturer's October 16 closing price.

BW LPG (NYSE:BWLP) reported approximately US$164 million in third-quarter gross trading results from its Product Services segment, with estimated net profit reaching US$118 million.

Telix Pharmaceuticals (NASDAQ:TLX) announced a collaboration with Ekalia to develop U.S. production of astatine-211, starting with one cyclotron installation near Philadelphia.

Oculis (NASDAQ:OCS) completed randomization of 176 patients in its PREDICT-1 registrational trial of Licaminlimab, advancing its development program for dry eye disease.

Elbit Systems (NASDAQ:ESLT) secured an approximately US$235 million contract to supply rocket artillery systems, including EXTRA-MR rockets and PULS launchers, to a European customer.

Evaxion (NASDAQ:EVAX) reported sustained clinical responses after three years in its phase 2 melanoma vaccine trial, with no tumor progression among six patients followed.

Werner Enterprises (NASDAQ:WERN) expects third-quarter 2026 revenue of $946 million to $951 million, with preliminary GAAP diluted earnings of $0.10 to $0.11 per share.

Tiziana Life Sciences (NASDAQ:TLSA) announced on October 16, 2026, that the final patient began dosing in its Phase 2 intranasal foralumab trial for early or mild Alzheimer’s disease.

Ladder Capital (NYSE:LADR) reported third-quarter 2026 GAAP income before taxes of $67.3 million and diluted earnings of $0.53 per share, supported by investment activity and an asset sale.

CLPS (NASDAQ:CLPS) reported fiscal 2026 revenue of $172.2 million, up 4.7%, despite a widening second-half net loss of $13.2 million.

Biomerica (NASDAQ:BMRA) reported a fiscal first-quarter 2027 net loss of $1.232 million, or $0.37 per share, as revenue declined 8% to $1.265 million.

NeOnc Technologies Holdings (NASDAQ:NTHI) reported early clinical improvements in one three-year-old brain tumor patient receiving investigational intranasal NEO100 through its Compassionate Care program in Abu Dhabi.

Private Bancorp of America (NASDAQ:PBAM) reported unaudited third-quarter 2026 net income of $11.4 million, with diluted earnings of $1.97 per share, reflecting year-over-year growth despite a sequential decline.

Aduro Clean Technologies (NASDAQ:ADUR) reported C$1.202 million in quarterly income for the period ended August 31, 2026, compared with a C$6.325 million loss a year earlier.

NN (NASDAQ:NNBR) launched its fourth product line of 2026, establishing a Cable Assembly and Wire Harness business with production centered in Ciudad Juárez, Mexico.

Zenta Group (NASDAQ:ZTG) said its ZentoAI subsidiary signed a memorandum of understanding to acquire control of a profitable mainland Chinese AI and digital technology provider.

Organon (NYSE:OGN) announced interim six-year Phase 3 results for its licensed hormone-free MIUDELLA contraceptive device, reporting a cumulative Pearl Index of 0.93.

Regeneron Pharmaceuticals (NASDAQ:REGN) announced a positive European regulatory recommendation allowing Libtayo dosing every six weeks across six approved cancer indications, subject to final authorization.

Fractyl Health (NASDAQ:GUTS) reported that its Revita procedure met a six-month co-primary endpoint in the 308-patient REMAIN-1 study, showing improved weight maintenance after GLP-1 treatment discontinuation.

Bowman Consulting Group (NASDAQ:BWMN) announced its acquisition of dymaptic on October 16, 2026, expanding its engineering business with geospatial AI and custom software development capabilities.

Travelers (NYSE:TRV) reported third-quarter 2026 net income of $1.917 billion, or $9.04 per diluted share, supported by underwriting and investment earnings.

Ionis Pharmaceuticals (NASDAQ:IONS) announced that European regulators recommended expanding TRYNGOLZA's indication to adults with severe hypertriglyceridemia and fasting triglycerides of at least 880 mg/dL.

GE Aerospace (NYSE:GE), through its CFM International joint venture with Safran, signed an agreement in principle covering more than 300 LEAP-1B engines for Turkish Airlines' Boeing 737 MAX fleet.